Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015
A pragmatic guide to choosing biologic therapies in severe asthma Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 Year: 2021
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015
Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013
An algorithmic approach for the treatment of severe uncontrolled asthma Source: ERJ Open Res, 4 (1) 00125-2017; 10.1183/23120541.00125-2017 Year: 2018
Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009
Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009
Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project) Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002
Biomarker-guided design to test clinical proof of concept in allergic respiratory diseases of UR-63325, a new H4 R antagonist Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010
Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008
Early prediction of childhood asthma exacerbations through a combination of statistical and machine learning approaches. Source: Virtual Congress 2020 – Risk factors, comorbidities and remote monitoring in childhood asthma Year: 2020
Non-drug methods in complex treatment of the severe bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 513s Year: 2002
Developing a novel in vitro 3D airway model to provide a viable alternative to animal use in asthma research Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012
Combining digital technologies to monitor asthma control and predict asthma exacerbations Source: Virtual Congress 2020 – Digital health: a brave new world? Year: 2020
Dose-FEV1 modeling to support future development of AZD2115, a dual acting bronchodilator for the treatment of COPD Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Synbiotics reduce airway inflammation and improve airway function in a mouse model for COPD Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012
A competence framework to support the development of the workforce to deliver improved outcomes for patients with COPD and asthma Source: Annual Congress 2012 - Professional development and advanced practice roles in respiratory nursing Year: 2012